Search - tctmd.com

Displaying 1 - 20 of 37

Sort: Relevancy | Date

Presentation TCT 2025

TCT 216: Outcomes based on the completeness of revascularization in patients with three-vessel coronary artery disease: The FAME 3 Trial

Presenter: Hisao Otsuki

October 26, 2025

Presentation TCT 2023

TCT 63: Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial

Presenter: Seung Hun Lee

October 26, 2023

Presentation TCT 2023

TCT 623: Effects of Complete Revascularization in Relation to Left Ventricular Function in Patients with STEMI and Multivessel Disease: Data from the COMPLETE Randomized trial

Presenter: Denise Tiong

October 26, 2023

Presentation TCT 2023

TCT 357: Immediate Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Extensive Coronary Artery Disease: Insights From the BIOVASC Trial

Presenter: Hala Kakar

October 26, 2023

Presentation TCT 2023

TCT 462: Immediate Versus Staged Complete Revascularisation Angina-Related Quality of Life in patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease : Results From the Prospective, Open-Label, Non-Inferiority, Randomised…

Presenter: Paul Cummins

October 26, 2023

Presentation TCT 2023

Impact of High Bleeding Risk status on comparative outcomes of Physiology-guided Complete versus Culprit-Only Revascularization in older MI patients: Data from the FIRE trial

Presenter: Simone Biscaglia

October 23, 2023

Presentation TCT 2022

TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

Presenter: Mick Renkens

September 17, 2022

Presentation TCT 2022

TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial

Presenter: Zardasht Oqab

September 17, 2022

Presentation TCT 2022

TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial

Presenter: Kevin Bainey

September 17, 2022

Presentation TCT 2021

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Presenter: Tobias Schmidt

November 05, 2021

Presentation TVT 2021

Complete 2-year Follow-Up from Evolut Low Risk Trial

Presenter: John Forrest

July 20, 2021

Presentation CACI 2019

Después del COMPLETE Trial, ¿cambió nuestra estrategia de revascularización en el IAM?

Presenter: José A. G. Álvarez

November 29, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease — Importance of Revascularization Timing

Presenter: David Wood

September 28, 2019

Presentation TCT 2019

The Case for Functional (Not Anatomic) Complete Revascularization: Preview of FAME 3

Presenter: William Fearon

September 27, 2019

Presentation TCT 2019

COMPLETE Trial: Focus on STEMI and MVD

Presenter: Shamir Mehta

September 26, 2019

Presentation TCT 2019

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Presenter: Navin Kapur

September 26, 2019

Presentation TCT 2019

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Presenter: Navin Kapur

September 26, 2019

Presentation SIF 2019

Complete revascularization in STEMI – what shall we do in 2019?

March 29, 2019

Presentation TCT 2018

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Presenter: Horst Sievert, Brian K. Whisenant, Jeffrey J. Popma

September 23, 2018

Advertisement

TCT 216: Outcomes based on the completeness of revascularization in patients with three-vessel coronary artery disease: The FAME 3 Trial

TCT 63: Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial

TCT 623: Effects of Complete Revascularization in Relation to Left Ventricular Function in Patients with STEMI and Multivessel Disease: Data from the COMPLETE Randomized trial

TCT 357: Immediate Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Extensive Coronary Artery Disease: Insights From the BIOVASC Trial

TCT 462: Immediate Versus Staged Complete Revascularisation Angina-Related Quality of Life in patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease : Results From the Prospective, Open-Label, Non-Inferiority, Randomised…

Impact of High Bleeding Risk status on comparative outcomes of Physiology-guided Complete versus Culprit-Only Revascularization in older MI patients: Data from the FIRE trial

TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial

TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Complete 2-year Follow-Up from Evolut Low Risk Trial

Después del COMPLETE Trial, ¿cambió nuestra estrategia de revascularización en el IAM?

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease — Importance of Revascularization Timing

The Case for Functional (Not Anatomic) Complete Revascularization: Preview of FAME 3

COMPLETE Trial: Focus on STEMI and MVD

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Complete revascularization in STEMI – what shall we do in 2019?

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content